Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis (Q34774221)

4 August 2017

1 reference

title

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis (English)

1 reference

4 August 2017

1 reference

Eva Lonn

1

1 reference

PubMed ID

12162936

4 August 2017

language of work or name

1 reference

1 September 2002

1 reference

Current Atherosclerosis Reports

4 August 2017

1 reference

4 August 2017

4

1 reference

4 August 2017

5

1 reference

4 August 2017

363-372

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-002-0074-7

4 August 2017

0 references

cites work

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

Angiotensin II type 2 receptors: signalling and pathophysiological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-002-0074-7

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women

1 reference

12 December 2020

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

12 December 2020

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

12 December 2020

Use of angiotensin II receptor blockers in animal models of atherosclerosis

1 reference

12 December 2020

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

12 December 2020

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

1 reference

12 December 2020

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function

1 reference

12 December 2020

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

1 reference

12 December 2020

Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril

1 reference

12 December 2020

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Effects of captopril on atherosclerosis in cynomolgus monkeys

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

12 December 2020

Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

12 December 2020

The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) Trial

1 reference

12 December 2020

Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers

1 reference

12 December 2020

Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1

1 reference

12 December 2020

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

12 December 2020

Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs.

1 reference

12 December 2020

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

12 December 2020

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis

1 reference

12 December 2020

Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction

1 reference

12 December 2020

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

12 December 2020

Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

1 reference

12 December 2020

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

1 reference

12 December 2020

10.1007/S11883-002-0074-7

Identifiers

DOI

1 reference

PubMed ID

12162936

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12162936